Circulating inflammatory cytokines and risk of five cancers: a Mendelian randomization analysis

Abstract

Our study adds to current knowledge on the role of specific inflammatory biomarker pathways in cancer aetiology. Further validation is needed to assess the potential of these cytokines as pharmacological or lifestyle targets for cancer prevention.